Published in Respir Physiol on April 01, 1987
Pulmonary circulation at exercise. Compr Physiol (2012) 1.06
Physiology in medicine: importance of hypoxic pulmonary vasoconstriction in maintaining arterial oxygenation during acute respiratory failure. Crit Care (2001) 0.90
Acute pulmonary oedema on the Ruwenzori mountain range. Br Heart J (1990) 0.87
Platelet-activating factor causes ventilation-perfusion mismatch in humans. J Clin Invest (1994) 0.78
Inhaled nitric oxide alters the distribution of blood flow in the healthy human lung, suggesting active hypoxic pulmonary vasoconstriction in normoxia. J Appl Physiol (1985) (2014) 0.78
Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA (2001) 10.03
Isolation of an Escherichia coli K-12 mutant strain able to form biofilms on inert surfaces: involvement of a new ompR allele that increases curli expression. J Bacteriol (1998) 4.33
Abiotic surface sensing and biofilm-dependent regulation of gene expression in Escherichia coli. J Bacteriol (1999) 4.26
Erythropoietin response is blunted in critically ill patients. Intensive Care Med (1997) 3.20
Sedative and analgesic practice in the intensive care unit: the results of a European survey. Br J Anaesth (2001) 2.75
Developmental pathway for biofilm formation in curli-producing Escherichia coli strains: role of flagella, curli and colanic acid. Environ Microbiol (2000) 2.56
Methylene blue administration in septic shock: a clinical trial. Crit Care Med (1995) 2.50
Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil. Eur Respir J (2006) 2.39
Complex regulatory network controls initial adhesion and biofilm formation in Escherichia coli via regulation of the csgD gene. J Bacteriol (2001) 2.35
The H-NS protein is involved in the biogenesis of flagella in Escherichia coli. J Bacteriol (1994) 2.24
End points in pulmonary arterial hypertension: the way forward. Eur Respir J (2004) 2.21
A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. European Epinephrine Study Group. N Engl J Med (1998) 2.18
Relation between oxygen consumption and oxygen delivery in patients after cardiac surgery. Anesth Analg (1993) 2.12
Chromosome transfer and R-prime plasmid formation mediated by plasmid pULB113 (RP4::mini-Mu) in Alcaligenes eutrophus CH34 and Pseudomonas fluorescens 6.2. J Bacteriol (1983) 2.12
Pulmonary hypertension in COPD. Eur Respir J (2008) 2.03
Involvement of the Cpx signal transduction pathway of E. coli in biofilm formation. FEMS Microbiol Lett (1999) 1.83
Multiple sclerosis-like disorder in OPA1-related autosomal dominant optic atrophy. Neurology (2008) 1.78
The role of carbohydrates in the induction of flowering in Arabidopsis thaliana: comparison between the wild type and a starchless mutant. Planta (1998) 1.77
Selective intestinal decontamination in multiple trauma patients: prospective, controlled trial. J Trauma (1997) 1.64
Isolated right ventricular dysfunction in systemic sclerosis: latent pulmonary hypertension? Eur Respir J (2007) 1.63
Optimising the management of pulmonary arterial hypertension patients: emergency treatments. Eur Respir Rev (2010) 1.62
Long term treatment of pulmonary arterial hypertension with beraprost, an oral prostacyclin analogue. Heart (2001) 1.59
High-altitude pulmonary edema is initially caused by an increase in capillary pressure. Circulation (2001) 1.54
A Xanthomonas campestris pv. campestris protein similar to catabolite activation factor is involved in regulation of phytopathogenicity. J Bacteriol (1990) 1.51
The hepatopulmonary syndrome: NO way out? Eur Respir J (2004) 1.49
Systemic vascular effects of isoflurane versus propofol anesthesia in dogs. Anesth Analg (1996) 1.48
Prostaglandin E1 infusion for right ventricular failure after cardiac transplantation. J Thorac Cardiovasc Surg (1992) 1.42
Are multiple blood transfusions really a cause of acute respiratory distress syndrome? Eur J Anaesthesiol (2006) 1.41
Addition of enoximone to adrenergic agents in the management of severe heart failure. Crit Care Med (1992) 1.40
Diagnosis and treatment of an unusual cause of metabolic acidosis: ethylene glycol poisoning. Acta Clin Belg (1999) 1.40
A 2-year prospective longitudinal study on low back pain in primary school children. Eur Spine J (2002) 1.39
Low back pain in a population of school children. Eur Spine J (1999) 1.33
Mutations in bglY, the structural gene for the DNA-binding protein H1, affect expression of several Escherichia coli genes. Biochimie (1990) 1.25
Shuttle transfer (or retrotransfer) of chromosomal markers mediated by plasmid pULB113. Mol Gen Genet (1987) 1.24
More on the noninvasive diagnosis of pulmonary hypertension: Doppler echocardiography revisited. Eur Respir J (1995) 1.22
Clinical relevance of autonomic nervous system disturbances in pulmonary arterial hypertension. Eur Respir J (2009) 1.20
End-points and clinical trial design in pulmonary arterial hypertension: have we made progress? Eur Respir J (2009) 1.18
Treatment of portal hypertension with isosorbide dinitrate alone and in combination with vasopressin. Crit Care Med (1983) 1.16
Right atrial thrombus leading to pulmonary embolism. Br Heart J (1984) 1.15
Exercise stress echocardiography for the study of the pulmonary circulation. Eur Respir J (2009) 1.15
Inappropriate secretion of antidiuretic hormone treated with frusemide. Br Med J (Clin Res Ed) (1982) 1.11
Bone morphogenetic protein signalling in heritable versus idiopathic pulmonary hypertension. Eur Respir J (2009) 1.11
The H-NS protein modulates the activation of the ilvIH operon of Escherichia coli K12 by Lrp, the leucine regulatory protein. Mol Gen Genet (1994) 1.08
Pulmonary vascular impedance vs. resistance in hypoxic and hyperoxic dogs: effects of propofol and isoflurane. J Appl Physiol (1985) (1993) 1.07
Demeclocycline treatment of water retention in congestive heart failure. Br Med J (1978) 1.07
Nitric oxide synthase in human breast cancer is associated with tumor grade, proliferation rate, and expression of progesterone receptors. Lab Invest (1999) 1.07
Thermodilution measurement of right ventricular ejection fraction with a modified pulmonary artery catheter. Intensive Care Med (1986) 1.06
Permissive hypercapnia impairs pulmonary gas exchange in the acute respiratory distress syndrome. Am J Respir Crit Care Med (2000) 1.05
Deleterious effect of nifedipine on pulmonary gas exchange in chronic obstructive pulmonary disease. Am Rev Respir Dis (1984) 1.04
Effects of vasodilators on hypoxic pulmonary vasoconstriction in normal man. Chest (1982) 1.04
CCM3 Mutations Are Associated with Early-Onset Cerebral Hemorrhage and Multiple Meningiomas. Mol Syndromol (2013) 1.03
Echocardiographic and invasive measurements of pulmonary artery pressure correlate closely at high altitude. Am J Physiol Heart Circ Physiol (2000) 1.02
Pathobiology of pulmonary arterial hypertension. Eur Respir J (2002) 0.99
Monitoring gene expression in biofilms. Methods Enzymol (1999) 0.97
Effects of acidosis and alkalosis on hypoxic pulmonary vasoconstriction in dogs. Am J Physiol (1990) 0.97
Exercise testing in pulmonary arterial hypertension and in chronic heart failure. Eur Respir J (2004) 0.97
Effects of nifedipine on ventilation/perfusion matching in primary pulmonary hypertension. Chest (1983) 0.96
[Malignant non-Hodgkin lymphoma presenting with Garcin's syndrome]. Rev Neurol (Paris) (2004) 0.96
Three percent diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses: a meta-analysis of the recent studies. Arch Dermatol Res (2005) 0.95
Treatment of diabetic coma with small intravenous insulin boluses. Br Med J (1976) 0.95
Establishing research strategies, methodologies and technologies to link genomics and proteomics to seagrass productivity, community metabolism, and ecosystem carbon fluxes. Front Plant Sci (2013) 0.94
Pulse pressure method and the area method for the estimation of total arterial compliance in dogs: sensitivity to wave reflection intensity. Ann Biomed Eng (1999) 0.94
Improvement in ventilation-perfusion matching by almitrine in COPD. Chest (1983) 0.94
Effects of hypoxic pulmonary vasoconstriction on pulmonary gas exchange. J Appl Physiol (1985) (1996) 0.93
Single arterial occlusion to locate resistance in patients with pulmonary hypertension. Eur Respir J (2003) 0.93
High uric acid and urea clearance in cirrhosis secondary to increased "effective vascular volume". Am J Med (1982) 0.93
Prostaglandin E1 in the adult respiratory distress syndrome. Benefit for pulmonary hypertension and cost for pulmonary gas exchange. Am Rev Respir Dis (1989) 0.93
Fructose catabolism in Xanthomonas campestris pv. campestris. Sequence of the PTS operon, characterization of the fructose-specific enzymes. J Biol Chem (1991) 0.92
Partitioning of pulmonary vascular resistance in primary pulmonary hypertension. J Am Coll Cardiol (1998) 0.91
Relationship of middle cerebral artery blood flow velocity to intensity during dynamic exercise in normal subjects. Eur J Appl Physiol Occup Physiol (1993) 0.91
Thoracoscopy in oesophagectomy for oesophageal cancer. Br J Surg (1993) 0.91
CDP571, a humanized antibody to human tumor necrosis factor-alpha: safety, pharmacokinetics, immune response, and influence of the antibody on cytokine concentrations in patients with septic shock. CPD571 Sepsis Study Group. Crit Care Med (1995) 0.90
Sympathetic modulation of hypoxic pulmonary vasoconstriction in intact dogs. Cardiovasc Res (1997) 0.90
The value of tools to assess pulmonary arterial hypertension. Eur Respir Rev (2011) 0.90
Physiological response to the six-minute walk test in pulmonary arterial hypertension. Eur Respir J (2005) 0.90
Pulmonary and extrapulmonary contributors to hypoxemia in liver cirrhosis. Am Rev Respir Dis (1989) 0.90